Literature DB >> 11249160

Nonoperative treatment for lumbar spinal stenosis.

A C Simotas1.   

Abstract

The natural history of degenerative lumbar spinal stenosis is documented poorly. Little is known about the efficacy of nonoperative treatments. An aggressive nonoperative treatment consisting of therapeutic exercise, analgesics, and epidural steroid injections is proposed. The clinical evaluation of the patients is reviewed and the relevance to the selection of the nonoperative treatment plans is emphasized. Efficacy of nonoperative treatment may depend greatly on the nature and severity of the patient's symptomatic and radiographic presentation. Several studies on nonoperative treatment of patients with between 1 and 5 years of followup suggest that variably 15% to 43% of patients will have continued improvement after nonoperative treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11249160     DOI: 10.1097/00003086-200103000-00018

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  16 in total

1.  Insertion loads of the X STOP interspinous process distraction system designed to treat neurogenic intermittent claudication.

Authors:  Vikram Talwar; Derek P Lindsey; Amy Fredrick; Ken Y Hsu; James F Zucherman; Scott A Yerby
Journal:  Eur Spine J       Date:  2005-05-31       Impact factor: 3.134

2.  Randomised placebo-controlled trial on the effectiveness of nasal salmon calcitonin in the treatment of lumbar spinal stenosis.

Authors:  Suhayl I Tafazal; Leslie Ng; Philip Sell
Journal:  Eur Spine J       Date:  2006-07-25       Impact factor: 3.134

3.  Patient-based outcomes for the operative treatment of degenerative lumbar spinal stenosis.

Authors:  Samo K Fokter; Scott A Yerby
Journal:  Eur Spine J       Date:  2005-12-21       Impact factor: 3.134

Review 4.  [Lumbar spinal stenosis].

Authors:  T L Schulte; V Bullmann; T Lerner; M Schneider; B Marquardt; U Liljenqvist; T A Pietilä; L Hackenberg
Journal:  Orthopade       Date:  2006-06       Impact factor: 1.087

5.  Clinical outcomes following sublaminar-trimming laminoplasty for extensive lumbar canal stenosis.

Authors:  Wen-Jiunn Liu; Shih-Wun Hong; Da-Yon Liou; Tung-Wu Lu
Journal:  Eur Spine J       Date:  2013-07-13       Impact factor: 3.134

6.  Postoperative rehabilitation does not improve functional outcome in lumbar spinal stenosis: a prospective study with 2-year postoperative follow-up.

Authors:  Timo J Aalto; Ville Leinonen; Arto Herno; Markku Alen; Heikki Kröger; Veli Turunen; Sakari Savolainen; Tapani Saari; Olavi Airaksinen
Journal:  Eur Spine J       Date:  2011-04-27       Impact factor: 3.134

7.  A prospective randomized multi-center study for the treatment of lumbar spinal stenosis with the X STOP interspinous implant: 1-year results.

Authors:  J F Zucherman; K Y Hsu; C A Hartjen; T F Mehalic; D A Implicito; M J Martin; D R Johnson; G A Skidmore; P P Vessa; J W Dwyer; S Puccio; J C Cauthen; R M Ozuna
Journal:  Eur Spine J       Date:  2003-12-19       Impact factor: 3.134

Review 8.  Lumbar spinal stenosis: syndrome, diagnostics and treatment.

Authors:  Eberhard Siebert; Harald Prüss; Randolf Klingebiel; Vieri Failli; Karl M Einhäupl; Jan M Schwab
Journal:  Nat Rev Neurol       Date:  2009-07       Impact factor: 42.937

9.  Design of the Verbiest trial: cost-effectiveness of surgery versus prolonged conservative treatment in patients with lumbar stenosis.

Authors:  Gijsbert M Overdevest; Pim A J Luijsterburg; Ronald Brand; Bart W Koes; Sita M A Bierma-Zeinstra; Just A H Eekhof; Carmen L A M Vleggeert-Lankamp; Wilco C Peul
Journal:  BMC Musculoskelet Disord       Date:  2011-03-03       Impact factor: 2.362

10.  Assessment and management of neurogenic claudication associated with lumbar spinal stenosis in a UK primary care musculoskeletal service: a survey of current practice among physiotherapists.

Authors:  Christine M Comer; Anthony C Redmond; Howard A Bird; Philip G Conaghan
Journal:  BMC Musculoskelet Disord       Date:  2009-10-01       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.